Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Colorectal Neoplasms

  Free Subscription

Articles published in Eur J Gastroenterol Hepatol

Retrieve available abstracts of 36 articles:
HTML format

Single Articles

    July 2021
  1. ROJAS A, Gachabayov M, Tewari V, Veillette G, et al
    Clostridium septicum liver abscess following colonoscopic stenting of transverse colon cancer.
    Eur J Gastroenterol Hepatol. 2021;33:1032-1033.

    May 2021
    Approval of pembrolizumab for first-line treatment of microsatellite instability-high/mismatch repair deficient colorectal cancer: estimation of incremental benefit based on restricted mean survival time.
    Eur J Gastroenterol Hepatol. 2021;33:763.

    February 2021
  3. GUO C, Wu J, Jiao Y, Zhang Q, et al
    Design and verification of individualized follow-up strategy of colonoscopy for postoperative patients with colorectal cancer.
    Eur J Gastroenterol Hepatol. 2021 Feb 5. pii: 00042737-900000000-97301.
    PubMed     Abstract available

    November 2020
  4. DI LEO M, Zuppardo RA, Puzzono M, Ditonno I, et al
    Risk factors and clinical characteristics of early-onset colorectal cancer vs. late-onset colorectal cancer: a case-case study.
    Eur J Gastroenterol Hepatol. 2020 Nov 17. doi: 10.1097/MEG.0000000000002000.
    PubMed     Abstract available

    July 2020
  5. TOUCHEFEU Y, Duchalais E, Bruley des Varannes S, Alameddine J, et al
    Concomitant decrease of double-positive lymphocyte population CD4CD8alphaalpha and Faecalibacterium prausnitzii in patients with colorectal cancer.
    Eur J Gastroenterol Hepatol. 2020 Jul 14. doi: 10.1097/MEG.0000000000001842.
    PubMed     Abstract available

    June 2020
  6. BASARANOGLU M, Kapsigay M, Kunduz E
    Increased neuroendocrine tumours, but small colorectal cancer incidence in patients with inflammatory bowel disease treated by mesalazine.
    Eur J Gastroenterol Hepatol. 2020;32:763.

    January 2020
  7. HAUG U, Coupe VMH
    The cumulative false-positive rate in colorectal cancer screening: a Markov analysis.
    Eur J Gastroenterol Hepatol. 2020 Jan 21. doi: 10.1097/MEG.0000000000001669.
    PubMed     Abstract available

    December 2019
  8. MANNUCCI A, Zuppardo RA, Crippa S, Carrera P, et al
    MSH6 gene pathogenic variant identified in familial pancreatic cancer in the absence of colon cancer.
    Eur J Gastroenterol Hepatol. 2019 Dec 16. doi: 10.1097/MEG.0000000000001617.
    PubMed     Abstract available

    November 2019
  9. WEN S, Chen N, Peng J, Ling W, et al
    Peripheral monocyte counts predict the clinical outcome for patients with colorectal cancer: a systematic review and meta-analysis.
    Eur J Gastroenterol Hepatol. 2019;31:1313-1321.
    PubMed     Abstract available

  10. VIOLA A, Monterubbianesi R, Scalisi G, Furfaro F, et al
    Late-onset Crohn's disease: a comparison of disease behaviour and therapy with younger adult patients: the Italian Group for the Study of Inflammatory Bowel Disease 'AGED' study.
    Eur J Gastroenterol Hepatol. 2019;31:1361-1369.
    PubMed     Abstract available

    October 2019
  11. LOKTIONOV A, Soubieres A, Bandaletova T, Mathur J, et al
    Colorectal cancer detection by biomarker quantification in noninvasively collected colorectal mucus: preliminary comparison of 24 protein biomarkers.
    Eur J Gastroenterol Hepatol. 2019;31:1220-1227.
    PubMed     Abstract available

    September 2019
  12. PASHA HF, Radwan MI, Yehia AM, Toam MM, et al
    Circulating methylated RUNX3 and SFRP1 genes as a noninvasive panel for early detection of colorectal cancer.
    Eur J Gastroenterol Hepatol. 2019 Sep 11. doi: 10.1097/MEG.0000000000001532.
    PubMed     Abstract available

    May 2019
  13. SYMONDS EL, Cole SR, Lau SY, Steele S, et al
    The significance of the small adenoma: a longitudinal study of surveillance colonoscopy in an Australian population.
    Eur J Gastroenterol Hepatol. 2019;31:563-569.
    PubMed     Abstract available

    March 2019
  14. JOOSTE V, Bouvier AM, Bossard N, Uhry Z, et al
    Trends in probabilities of death owing to cancer and owing to other causes in patients with colon cancer.
    Eur J Gastroenterol Hepatol. 2019 Mar 1. doi: 10.1097/MEG.0000000000001387.
    PubMed     Abstract available

  15. VAN HERWAARDEN YJ, Pape S, Vink-Borger E, Dura P, et al
    Reasons why the diagnosis of serrated polyposis syndrome is missed.
    Eur J Gastroenterol Hepatol. 2019;31:340-344.
    PubMed     Abstract available

    February 2019
  16. WANG SL, Wang Q, Yao J, Zhao SB, et al
    Effect of WeChat and short message service on bowel preparation: an endoscopist-blinded, randomized controlled trial.
    Eur J Gastroenterol Hepatol. 2019;31:170-177.
    PubMed     Abstract available

    January 2019
  17. DE KLERK CM, Woudstra AJ, Fransen MP, Bossuyt PM, et al
    Invitees do not adequately act on alarm symptoms in colorectal cancer screening with fecal immunochemical tests.
    Eur J Gastroenterol Hepatol. 2019;31:141-142.

  18. SHEN W, Tao G, Zhang Y, Tian Z, et al
    Prognostic value and interobserver variation of endoscopic ultrasound in the staging of rectal cancer.
    Eur J Gastroenterol Hepatol. 2019;31:142-143.

    December 2018
  19. IDIGORAS RUBIO I, Arana-Arri E, Portillo Villares I, Bilbao Iturribarrria I, et al
    Participation in a population-based screening for colorectal cancer using the faecal immunochemical test decreases mortality in 5 years.
    Eur J Gastroenterol Hepatol. 2018 Dec 12. doi: 10.1097/MEG.0000000000001338.
    PubMed     Abstract available

  20. DOS SANTOS CEO, Malaman D, Yoshida N, Pereira-Lima JC, et al
    Blue laser imaging: a new image-enhanced endoscopy for the diagnosis of colorectal lesions.
    Eur J Gastroenterol Hepatol. 2018;30:1514-1520.
    PubMed     Abstract available

  21. GKOLFAKIS P, Tziatzios G, Facciorusso A, Muscatiello N, et al
    Meta-analysis indicates that add-on devices and new endoscopes reduce colonoscopy adenoma miss rate.
    Eur J Gastroenterol Hepatol. 2018;30:1482-1490.
    PubMed     Abstract available

    November 2018
  22. MUJTABA S, Bostick RM
    Differences in risk factor-colorectal adenoma associations according to non-steroidal anti-inflammatory drug use.
    Eur J Gastroenterol Hepatol. 2018;30:1318-1326.
    PubMed     Abstract available

    October 2018
  23. VAN DE WETERING AJP, Bogie RMM, Cabbolet ACOG, Winkens B, et al
    Update on the role of chromoendoscopy in colonoscopic surveillance of patients with Lynch syndrome.
    Eur J Gastroenterol Hepatol. 2018;30:1116-1124.
    PubMed     Abstract available

    September 2018
  24. EL HAJJ II, DeWitt J, Sherman S, Imperiale TF, et al
    Prospective evaluation of the performance and interobserver variation in endoscopic ultrasound staging of rectal cancer.
    Eur J Gastroenterol Hepatol. 2018;30:1013-1018.
    PubMed     Abstract available

    August 2018
  25. LUISA AM, Mercedes AM, Jose BA, Ana BM, et al
    Factors related to colorectal cancer in advanced adenomas and serrated polyps: a further step toward individualized surveillance.
    Eur J Gastroenterol Hepatol. 2018 Aug 6. doi: 10.1097/MEG.0000000000001227.
    PubMed     Abstract available

  26. KOTZEV AI, Yang D, Draganov PV
    Practical approach for endoscopic resection of colorectal lesions: when West meets East.
    Eur J Gastroenterol Hepatol. 2018;30:827.

    July 2018
  27. ISLAM MM, Poly TN, Walther BA, Dubey NK, et al
    Adverse outcomes of long-term use of proton pump inhibitors: a systematic review and meta-analysis.
    Eur J Gastroenterol Hepatol. 2018 Jul 19. doi: 10.1097/MEG.0000000000001198.
    PubMed     Abstract available

  28. LAPUMNUAYPOL K, Mahmood E, Chaiwatcharayut W, Bandres MV, et al
    Colorectal cancer in young African Americans: clinical characteristics and presentations.
    Eur J Gastroenterol Hepatol. 2018 Jul 16. doi: 10.1097/MEG.0000000000001205.
    PubMed     Abstract available

    May 2018
  29. DERIKX LAAP, de Jong ME, Hoentjen F
    Recommendations on rectal surveillance for colorectal cancer after subtotal colectomy in patients with inflammatory bowel disease.
    Eur J Gastroenterol Hepatol. 2018 May 17. doi: 10.1097/MEG.0000000000001171.
    PubMed     Abstract available

  30. CATALANO C, da Silva Filho MI, Jiraskova K, Vymetalkova V, et al
    Influence of regulatory NLRC5 variants on colorectal cancer survival and 5-fluorouracil-based chemotherapy.
    Eur J Gastroenterol Hepatol. 2018 May 14. doi: 10.1097/MEG.0000000000001154.
    PubMed     Abstract available

  31. OJIDU H, Palmer H, Lewandowski J, Hampton J, et al
    Patient tolerance and acceptance of different colonic imaging modalities: an observational cohort study.
    Eur J Gastroenterol Hepatol. 2018;30:520-525.
    PubMed     Abstract available

  32. EMMANUEL A, Gulati S, Burt M, Hayee B, et al
    Combining eastern and western practices for safe and effective endoscopic resection of large complex colorectal lesions.
    Eur J Gastroenterol Hepatol. 2018;30:506-513.
    PubMed     Abstract available

    March 2018
  33. NIV Y
    Polyp detection rate may predict adenoma detection rate: a meta-analysis.
    Eur J Gastroenterol Hepatol. 2018;30:247-251.
    PubMed     Abstract available

    February 2018
  34. AI X, Qiao W, Han Z, Tan W, et al
    Results of a second examination of the right side of the colon in screening and surveillance colonoscopy: a systematic review and meta-analysis.
    Eur J Gastroenterol Hepatol. 2018;30:181-186.
    PubMed     Abstract available

    January 2018
  35. FENIG Y, Khoury M, Schmilovitz-Weiss H, Gingold-Belfer R, et al
    The outcome of transanal endoscopic microsurgery in obese patients.
    Eur J Gastroenterol Hepatol. 2018;30:113-117.
    PubMed     Abstract available

    November 2017
  36. LEE JW, Baek MJ, Ahn TS, Lee SM, et al
    Fluorine-18-fluorodeoxyglucose uptake of bone marrow on PET/CT can predict prognosis in patients with colorectal cancer after curative surgical resection.
    Eur J Gastroenterol Hepatol. 2017 Nov 8. doi: 10.1097/MEG.0000000000001018.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Colorectal Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.